Related Experiment Video
Updated: Jan 16, 2026
11:33
Synthesis of Infectious Bacteriophages in an E. coli-based Cell-free Expression System
Published on: August 17, 2017
15.5K
Engineered bacteriophages for therapeutic and diagnostic applications.
Kandas Traore1,2, Damien Seyer1, Agnes Mihajlovski1
1CY Cergy Paris Université, ERRMECe Laboratory, Biomaterials for Health Group, Neuville Sur-Oise 95031, France.
Disease Models & Mechanisms
|September 30, 2025
Summary
Engineered bacteriophages offer a promising solution to combat antimicrobial resistance. These modified phages can be tailored for enhanced effectiveness and diverse applications, complementing traditional antibiotics.
Area of Science:
- Microbiology
- Biotechnology
- Public Health
Background:
- Antimicrobial resistance (AMR) poses a significant global threat to public health and economic stability.
- Bacteriophages (phages) are viruses that infect bacteria and are being explored as a therapeutic alternative to antibiotics.
- Phages possess a narrow host spectrum, minimal side effects, and self-replication capabilities, making them attractive for treating bacterial infections.
Purpose of the Study:
- To highlight the relevance of engineered phages as an innovative solution to antimicrobial resistance.
- To provide an overview of bacteriophage biology, therapeutic history, and their role in One Health strategies.
- To discuss advanced engineering techniques and novel applications of engineered phages.
Main Methods:
- Review of bacteriophage life cycle, ecology, and therapeutic history.
- Description of advanced genetic engineering techniques for phage modification.
- Exploration of innovative applications of engineered phages in various fields.
Main Results:
- Engineered phages can be developed to enhance effectiveness and safety for therapeutic use.
- Phages can be utilized as gene and drug delivery vehicles for targeted bacterial and eukaryotic cells.
- Applications span from combating antimicrobial resistance to vaccine development and tissue engineering.
Conclusions:
- Engineered bacteriophages represent a versatile and innovative strategy to address the growing challenge of antimicrobial resistance.
- Advanced phage engineering expands their therapeutic potential and biotechnological applications.
- Phage therapy, particularly with engineered phages, holds significant promise for future healthcare and One Health initiatives.
Related Concept Videos
01:30Lytic Cycle of Bacteriophages
77.4K
Bacteriophages, also known as phages, are specialized viruses that infect bacteria. A key characteristic of phages is their distinctive “head-tail” morphology. A phage begins the infection process (i.e., lytic cycle) by attaching to the outside of a bacterial cell. Attachment is accomplished via proteins in the phage tail that bind to specific receptor proteins on the outer surface of the bacterium. The tail injects the phage’s DNA genome into the bacterial cytoplasm. In the...
77.4K
01:26DNA Bacteriophages
819
Bacteriophages, or phages, are viruses that specifically infect bacteria, utilizing their genetic material to hijack host cellular machinery for replication. DNA bacteriophages employ single-stranded DNA (ssDNA) or double-stranded DNA (dsDNA) genomes. These phages exhibit diverse replication strategies and host interactions, influencing their ecological roles and applications in biotechnology and medicine.ssDNA BacteriophagesssDNA phages, with their small genomes, utilize unique strategies to...
819
01:29Microorganisms in Medicine and Therapeutics
982
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
982
00:43Lysogenic Cycle of Bacteriophages
67.3K
In contrast to the lytic cycle, phages infecting bacteria via the lysogenic cycle do not immediately kill their host cell. Instead, they combine their genome with the host genome, allowing the bacteria to replicate the phage DNA along with the bacterial genome. The incorporated copy of the phage genome is called the prophage. Some prophages can re-activate and enter the lytic cycle. This often occurs in response to a perturbation, such as DNA damage, but can also transpire in the absence of...
67.3K
01:20Viral Replication: Lytic Cycle
1.3K
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
1.3K
02:53CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K